Anti-hypertensive Medication Dosing Regimen in Effective Blood Pressure Control

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 103 participants.

Also called NCT01669928

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 103 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01669928
Other papers using this trial's data
  • Randomized Crossover Trial of the Impact of Morning or Evening Dosing of Antihypertensive Agents on 24-Hour Ambulatory Blood Pressure Hypertension (Dallas, Tex. : 1979), 2018-10 DOI, PubMed 30354703

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Greece, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01669928. Randomized; no masking; primary purpose treatment. Start 2012-04 (actual); primary completion 2015-07 (actual). Results posted on 2021-03-08.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Anti-hypertensive Medication Dosing Regimen in Effective Blood Pressure Control
Acronym
HARMONY
Condition
Hypertension
Intervention (Drug)
Anti-hypertensive Medication -
Lead sponsor
Imperial College London (class: other)
Collaborator
Aristotle University Of Thessaloniki (class: other)

Record details

Record id
cardio:ct-nct01669928
Content hash
c1fd8688c44bc6a23581f7ed8e3cf1713eaf5d9f34b45e2925aaab802772956c